Published in BMJ on October 26, 1996
A framework for public health action: the health impact pyramid. Am J Public Health (2010) 9.45
Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol (2010) 3.23
Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association. Circulation (2012) 2.95
Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Trop Med Int Health (2008) 2.86
Palm oil taxes and cardiovascular disease mortality in India: economic-epidemiologic model. BMJ (2013) 1.81
Diseases of comfort: primary cause of death in the 22nd century. J Epidemiol Community Health (2005) 1.62
Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open (2013) 1.01
Global prevention and control of NCDs: Limitations of the standard approach. J Public Health Policy (2015) 1.00
Multi-Country analysis of palm oil consumption and cardiovascular disease mortality for countries at different stages of economic development: 1980-1997. Global Health (2011) 0.91
Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study. Eur J Cardiovasc Prev Rehabil (2010) 0.84
Reformulating partially hydrogenated vegetable oils to maximise health gains in India: is it feasible and will it meet consumer demand? BMC Public Health (2013) 0.83
Coronary heart disease risk factors in college students. Adv Nutr (2014) 0.80
Five-year changes in adiposity and cardio-metabolic risk factors among Guatemalan young adults. Public Health Nutr (2008) 0.76
Interventions addressing risk factors of ischaemic heart disease in sub-Saharan Africa: a systematic review. BMJ Open (2016) 0.75
Fall in cholesterol after changes in composition of cooking oil in Mauritius. BMJ (1997) 0.75
The limitations of opportunistic epidemiology, pseudopod epidemiology. Eur J Epidemiol (2016) 0.75
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med (1989) 15.67
Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb (1992) 3.15
Effect of dietary stearic acid on plasma cholesterol and lipoprotein levels. N Engl J Med (1988) 2.37
High prevalence of NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Mauritius Noncommunicable Disease Study Group. Diabetes (1990) 2.01
Comparison of effects of lauric acid and palmitic acid on plasma lipids and lipoproteins. Am J Clin Nutr (1992) 1.67
Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest (1993) 1.29
The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med (1993) 1.06
Prevalence and medical care of hypertension in four ethnic groups in the newly-industrialized nation of Mauritius. J Hypertens (1991) 0.98
Essential fatty acid status during early human development. Early Hum Dev (1992) 0.95
Global and societal implications of the diabetes epidemic. Nature (2001) 25.18
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 18.51
Haplotype tagging for the identification of common disease genes. Nat Genet (2001) 11.27
The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med (1997) 7.65
High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation (1992) 7.11
Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet (2000) 6.94
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet (1993) 6.53
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ (1999) 6.40
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med (2002) 6.32
Local research ethics committees. BMJ (1995) 6.30
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Preventing non-insulin-dependent diabetes. Diabetes (1995) 6.16
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Early growth and coronary heart disease in later life: longitudinal study. BMJ (2001) 5.25
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ (1999) 5.17
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trends. Diabetologia (1999) 5.11
Medical errors: a common problem. BMJ (2001) 4.69
Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care (2000) 4.62
The community-based strategy to prevent coronary heart disease: conclusions from the ten years of the North Karelia project. Annu Rev Public Health (1985) 4.30
The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med (2000) 4.29
Do cardiovascular risk factors explain the relation between socioeconomic status, risk of all-cause mortality, cardiovascular mortality, and acute myocardial infarction? Am J Epidemiol (1996) 4.23
Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). Br Med J (Clin Res Ed) (1983) 4.00
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
The genetically isolated populations of Finland and sardinia may not be a panacea for linkage disequilibrium mapping of common disease genes. Nat Genet (2000) 3.92
Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ (1994) 3.92
International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med (2007) 3.88
Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia project). Br Med J (1979) 3.75
Comparison of non-mydriatic retinal photography with ophthalmoscopy in 2159 patients: mobile retinal camera study. BMJ (1990) 3.65
Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study. BMJ (1997) 3.63
Midlife vascular risk factors and late-life mild cognitive impairment: A population-based study. Neurology (2001) 3.56
Dietary fibres, fibre analogues, and glucose tolerance: importance of viscosity. Br Med J (1978) 3.54
Stroke mortality in urban and rural Tanzania. Adult Morbidity and Mortality Project. Lancet (2000) 3.53
Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ (2001) 3.48
A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia (1993) 3.35
Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia (1997) 3.34
Cell membrane dynamics and insulin resistance in non-insulin-dependent diabetes mellitus. Lancet (1995) 3.33
Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17
A European evidence-based guideline for the prevention of type 2 diabetes. Horm Metab Res (2010) 3.15
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Educational level, relative body weight, and changes in their association over 10 years: an international perspective from the WHO MONICA Project. Am J Public Health (2000) 3.08
The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia (2009) 3.05
Symptoms of chronic bronchitis and the risk of coronary disease. Lancet (1996) 3.03
Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men. Circulation (1995) 2.99
Theory and action for health promotion illustrations from the North Karelia Project. Am J Public Health (1982) 2.95
Enzymic fluorometric continuous-flow assays for blood glucose, lactate, pyruvate, alanine, glycerol, and 3-hydroxybutyrate. Clin Chem (1978) 2.93
Twenty-year trends in coronary risk factors in north Karelia and in other areas of Finland. Int J Epidemiol (1994) 2.91
Social class, health behaviour, and mortality among men and women in eastern Finland. BMJ (1995) 2.89
Unabsorbable carbohydrates and diabetes: Decreased post-prandial hyperglycaemia. Lancet (1976) 2.84
Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology (1998) 2.83
Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer. BMJ (1995) 2.80
Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Br Med J (Clin Res Ed) (1983) 2.80
Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (1999) 2.78
Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland. Circulation (1999) 2.78
Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74
Perceived health status and morbidity and mortality: evidence from the Kuopio ischaemic heart disease risk factor study. Int J Epidemiol (1996) 2.73
Changes in smoking, serum cholesterol and blood pressure levels during a community-based cardiovascular disease prevention program--the North Karelia Project. Am J Epidemiol (1981) 2.72
Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group. Diabetes Care (1998) 2.70
Prevalence of diabetes and impaired glucose tolerance in rural Tanzania. Lancet (1989) 2.69
Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol (1983) 2.60
Early adiposity rebound in childhood and risk of Type 2 diabetes in adult life. Diabetologia (2003) 2.60
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Inhibition of insulin secretion by somatostatin. Lancet (1973) 2.58
Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J (1978) 2.57
Glucose intolerance during diuretic therapy. Results of trial by the European Working Party on Hypertension in the Elderly. Lancet (1978) 2.56
Hypertension prevalence and care in an urban and rural area of Tanzania. J Hypertens (2000) 2.54
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet (1994) 2.50
Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J (2002) 2.46
Dietary factors determining diabetes and impaired glucose tolerance. A 20-year follow-up of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetes Care (1995) 2.44
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia (2011) 2.43
Training in academic medicine: a way forward for the new millennium. A discussion document from the Academic Medicine Committee of the Royal College of Physicians. J R Coll Physicians Lond (1999) 2.42
Impaired fasting glucose or impaired glucose tolerance. What best predicts future diabetes in Mauritius? Diabetes Care (1999) 2.41
Age, body mass index and Type 2 diabetes-associations modified by ethnicity. Diabetologia (2003) 2.37
Small doses of intramuscular insulin in the treatment of diabetic "coma". Lancet (1973) 2.36
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. Eur Heart J (2002) 2.31
Dietary flavonoids, antioxidant vitamins, and incidence of stroke: the Zutphen study. Arch Intern Med (1996) 2.30
Body mass index and the risk of Parkinson disease. Neurology (2006) 2.28
Initial effect of injury on ketone bodies and other blood metabolites. Lancet (1975) 2.27
Diagnostic criteria and quality control of the registration of stroke events in the MONICA project. Acta Med Scand Suppl (1988) 2.26
Education and dementia: what lies behind the association? Neurology (2007) 2.26
A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia (1994) 2.25
Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25